SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000011
Filing Date
2021-01-04
Accepted
2021-01-04 06:12:47
Documents
16
Period of Report
2020-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20201231.htm   iXBRL 8-K 71862
2 EX-10.1 eypt-ex101_19.htm EX-10.1 195968
3 EX-10.2 eypt-ex102_20.htm EX-10.2 81697
4 EX-99.1 eypt-ex991_21.htm EX-99.1 21376
5 GRAPHIC gytykqii3ewf000001.jpg GRAPHIC 4940
  Complete submission text file 0001564590-21-000011.txt   572679

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20201231.xsd EX-101.SCH 5784
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20201231_lab.xml EX-101.LAB 18719
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20201231_pre.xml EX-101.PRE 11181
9 EXTRACTED XBRL INSTANCE DOCUMENT eypt-8k_20201231_htm.xml XML 3421
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 21500072
SIC: 3826 Laboratory Analytical Instruments